269 related articles for article (PubMed ID: 29977037)
1. Knockout of secretin receptor reduces biliary damage and liver fibrosis in Mdr2
Zhou T; Wu N; Meng F; Venter J; Giang TK; Francis H; Kyritsi K; Wu C; Franchitto A; Alvaro D; Marzioni M; Onori P; Mancinelli R; Gaudio E; Glaser S; Alpini G
Lab Invest; 2018 Nov; 98(11):1449-1464. PubMed ID: 29977037
[TBL] [Abstract][Full Text] [Related]
2. Prolonged administration of a secretin receptor antagonist inhibits biliary senescence and liver fibrosis in Mdr2 -/- mice.
Wu N; Zhou T; Carpino G; Baiocchi L; Kyritsi K; Kennedy L; Ceci L; Chen L; Wu C; Kundu D; Barupala N; Franchitto A; Onori P; Ekser B; Gaudio E; Francis H; Glaser S; Alpini G
Hepatology; 2023 Jun; 77(6):1849-1865. PubMed ID: 36799446
[TBL] [Abstract][Full Text] [Related]
3. The secretin/secretin receptor axis modulates liver fibrosis through changes in transforming growth factor-β1 biliary secretion in mice.
Wu N; Meng F; Invernizzi P; Bernuzzi F; Venter J; Standeford H; Onori P; Marzioni M; Alvaro D; Franchitto A; Gaudio E; Glaser S; Alpini G
Hepatology; 2016 Sep; 64(3):865-79. PubMed ID: 27115285
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of p16 Decreases Biliary Damage and Liver Fibrosis in the Mdr2
Kyritsi K; Francis H; Zhou T; Ceci L; Wu N; Yang Z; Meng F; Chen L; Baiocchi L; Kundu D; Kennedy L; Liangpunsakul S; Wu C; Glaser S; Alpini G
Gene Expr; 2020 Nov; 20(2):89-103. PubMed ID: 32393417
[TBL] [Abstract][Full Text] [Related]
5. Secretin/secretin receptor signaling mediates biliary damage and liver fibrosis in early-stage primary biliary cholangitis.
Kennedy L; Francis H; Invernizzi P; Venter J; Wu N; Carbone M; Gershwin ME; Bernuzzi F; Franchitto A; Alvaro D; Marzioni M; Onori P; Gaudio E; Sybenga A; Fabris L; Meng F; Glaser S; Alpini G
FASEB J; 2019 Sep; 33(9):10269-10279. PubMed ID: 31251081
[TBL] [Abstract][Full Text] [Related]
6. Knockdown of vimentin reduces mesenchymal phenotype of cholangiocytes in the Mdr2
Zhou T; Kyritsi K; Wu N; Francis H; Yang Z; Chen L; O'Brien A; Kennedy L; Ceci L; Meadows V; Kusumanchi P; Wu C; Baiocchi L; Skill NJ; Saxena R; Sybenga A; Xie L; Liangpunsakul S; Meng F; Alpini G; Glaser S
EBioMedicine; 2019 Oct; 48():130-142. PubMed ID: 31522982
[TBL] [Abstract][Full Text] [Related]
7. The Secretin/Secretin Receptor Axis Modulates Ductular Reaction and Liver Fibrosis through Changes in Transforming Growth Factor-β1-Mediated Biliary Senescence.
Wu N; Meng F; Zhou T; Venter J; Giang TK; Kyritsi K; Wu C; Alvaro D; Onori P; Mancinelli R; Gaudio E; Francis H; Alpini G; Glaser S; Franchitto A
Am J Pathol; 2018 Oct; 188(10):2264-2280. PubMed ID: 30036520
[TBL] [Abstract][Full Text] [Related]
8. Knockout of the Tachykinin Receptor 1 in the Mdr2
Ceci L; Francis H; Zhou T; Giang T; Yang Z; Meng F; Wu N; Kennedy L; Kyritsi K; Meadows V; Wu C; Liangpunsakul S; Franchitto A; Sybenga A; Ekser B; Mancinelli R; Onori P; Gaudio E; Glaser S; Alpini G
Am J Pathol; 2020 Nov; 190(11):2251-2266. PubMed ID: 32712019
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of hepatic stem cell factor by Vivo-Morpholino treatment inhibits mast cell migration and decreases biliary damage/senescence and liver fibrosis in Mdr2
Meadows V; Kennedy L; Hargrove L; Demieville J; Meng F; Virani S; Reinhart E; Kyritsi K; Invernizzi P; Yang Z; Wu N; Liangpunsakul S; Alpini G; Francis H
Biochim Biophys Acta Mol Basis Dis; 2019 Dec; 1865(12):165557. PubMed ID: 31521820
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of Secretin/Secretin Receptor Axis Ameliorates NAFLD Phenotypes.
Chen L; Wu N; Kennedy L; Francis H; Ceci L; Zhou T; Samala N; Kyritsi K; Wu C; Sybenga A; Ekser B; Dar W; Atkins C; Meadows V; Glaser S; Alpini G
Hepatology; 2021 Oct; 74(4):1845-1863. PubMed ID: 33928675
[TBL] [Abstract][Full Text] [Related]
11. Amelioration of Ductular Reaction by Stem Cell Derived Extracellular Vesicles in MDR2 Knockout Mice via Lethal-7 microRNA.
McDaniel K; Wu N; Zhou T; Huang L; Sato K; Venter J; Ceci L; Chen D; Ramos-Lorenzo S; Invernizzi P; Bernuzzi F; Wu C; Francis H; Glaser S; Alpini G; Meng F
Hepatology; 2019 Jun; 69(6):2562-2578. PubMed ID: 30723922
[TBL] [Abstract][Full Text] [Related]
12. Prolonged darkness reduces liver fibrosis in a mouse model of primary sclerosing cholangitis by miR-200b down-regulation.
Wu N; Meng F; Zhou T; Han Y; Kennedy L; Venter J; Francis H; DeMorrow S; Onori P; Invernizzi P; Bernuzzi F; Mancinelli R; Gaudio E; Franchitto A; Glaser S; Alpini G
FASEB J; 2017 Oct; 31(10):4305-4324. PubMed ID: 28634212
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of microRNA-24 increases liver fibrosis by enhanced menin expression in Mdr2
Hall C; Ehrlich L; Meng F; Invernizzi P; Bernuzzi F; Lairmore TC; Alpini G; Glaser S
J Surg Res; 2017 Sep; 217():160-169. PubMed ID: 28602220
[TBL] [Abstract][Full Text] [Related]
14. Mast Cells Induce Ductular Reaction Mimicking Liver Injury in Mice Through Mast Cell-Derived Transforming Growth Factor Beta 1 Signaling.
Kyritsi K; Kennedy L; Meadows V; Hargrove L; Demieville J; Pham L; Sybenga A; Kundu D; Cerritos K; Meng F; Alpini G; Francis H
Hepatology; 2021 Jun; 73(6):2397-2410. PubMed ID: 32761972
[TBL] [Abstract][Full Text] [Related]
15. Genetic or pharmacological reduction of cholangiocyte senescence improves inflammation and fibrosis in the
Alsuraih M; O'Hara SP; Woodrum JE; Pirius NE; LaRusso NF
JHEP Rep; 2021 Jun; 3(3):100250. PubMed ID: 33870156
[TBL] [Abstract][Full Text] [Related]
16. The Effects of Taurocholic Acid on Biliary Damage and Liver Fibrosis Are Mediated by Calcitonin-Gene-Related Peptide Signaling.
Mancinelli R; Ceci L; Kennedy L; Francis H; Meadows V; Chen L; Carpino G; Kyritsi K; Wu N; Zhou T; Sato K; Pannarale L; Glaser S; Chakraborty S; Alpini G; Gaudio E; Onori P; Franchitto A
Cells; 2022 May; 11(9):. PubMed ID: 35563897
[TBL] [Abstract][Full Text] [Related]
17. The Apelin-Apelin Receptor Axis Triggers Cholangiocyte Proliferation and Liver Fibrosis During Mouse Models of Cholestasis.
Chen L; Zhou T; White T; O'Brien A; Chakraborty S; Liangpunsakul S; Yang Z; Kennedy L; Saxena R; Wu C; Meng F; Huang Q; Francis H; Alpini G; Glaser S
Hepatology; 2021 Jun; 73(6):2411-2428. PubMed ID: 32964473
[TBL] [Abstract][Full Text] [Related]
18. Endothelin Receptor-A Inhibition Decreases Ductular Reaction, Liver Fibrosis, and Angiogenesis in a Model of Cholangitis.
Owen T; Carpino G; Chen L; Kundu D; Wills P; Ekser B; Onori P; Gaudio E; Alpini G; Francis H; Kennedy L
Cell Mol Gastroenterol Hepatol; 2023; 16(4):513-540. PubMed ID: 37336290
[TBL] [Abstract][Full Text] [Related]
19. Substance P increases liver fibrosis by differential changes in senescence of cholangiocytes and hepatic stellate cells.
Wan Y; Meng F; Wu N; Zhou T; Venter J; Francis H; Kennedy L; Glaser T; Bernuzzi F; Invernizzi P; Glaser S; Huang Q; Alpini G
Hepatology; 2017 Aug; 66(2):528-541. PubMed ID: 28256736
[TBL] [Abstract][Full Text] [Related]
20. TGF-β2 silencing to target biliary-derived liver diseases.
Dropmann A; Dooley S; Dewidar B; Hammad S; Dediulia T; Werle J; Hartwig V; Ghafoory S; Woelfl S; Korhonen H; Janicot M; Wosikowski K; Itzel T; Teufel A; Schuppan D; Stojanovic A; Cerwenka A; Nittka S; Piiper A; Gaiser T; Beraza N; Milkiewicz M; Milkiewicz P; Brain JG; Jones DEJ; Weiss TS; Zanger UM; Ebert M; Meindl-Beinker NM
Gut; 2020 Sep; 69(9):1677-1690. PubMed ID: 31992593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]